BioSpace News Archive

We’re proud to celebrate Sarah M. Aiosa, SVP and president, Latin America, for being recognized as one of The Association of Latino Professionals for Americas’ 2023 Most Powerful Latinas!

Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced that it will host a conference call on November 9, 2023, at 4:30 PM Eastern Time to discuss results for its third quarter ended September 30, 2023.

Zevia PBC (“Zevia”) (NYSE:ZVIA) today announced that it will release its financial results for the third quarter ended September 30, 2023 before the market open on Tuesday, November 7, 2023 followed by a conference call at 8:30 a.m. Eastern Time to discuss the results.

Pulse Biosciences, Inc. today announced the appointment of Niv Ad, M.D. as Chief Science Officer, Cardiac Surgery.

CEL-SCI Corporation (NYSE American: CVM) today released a video presentation in which the Company’s CEO, Geert Kersten, shares the most recent data presented at the European Society for Medical Oncology (ESMO) Congress and the data’s impact on propelling the Company’s immunotherapy drug Multikine*.

MTF Biologics ® Receives First Investigational Device Exemption Approval for Human Acellular Dermal Matrix in Breast Reconstruction.

Aurion Biotech today announced that it has dosed the first subject in its Phase 1 / 2 U.S. clinical trial (ABA-1, CLARA) of AURN001.

Microbot Medical Inc., developer of the innovative LIBERTY® Robotic Surgical System, announces it has received confirmation for the commencement of the process to support its future CE Mark approval, and to ultimately allow the Company to market the LIBERTY® Robotic Surgical System in Europe as well as other regions who accept the CE Mark.

Ensysce Biosciences, Inc. announced today that it has entered into a securities purchase agreement with investors in the form of senior secured convertible notes.

Avertix Medical, Inc. announced The Guardian System™ data was presented at the Transcatheter Cardiovascular Therapeutics conference in San Francisco.